Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
6Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
ProKidney Corp. (PROK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
9Total relationships
1Distinct source URLs
3High confidence
0.716Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
ProKidney Corp. Suppliers
Ticker
Name
Confidence
Evidence
NEFRO-HEALTH
NEFRO-HEALTH
92%
Consulting Services Agreement between ProKidney-US and Nefro, pursuant to which Nefro provides consulting services for the research and development of the Company's product candidates
ProKidney Corp. Customers
Ticker
Name
Confidence
Evidence
DELAWARE-LIMITED-LIABILITY-COMPANY
DELAWARE-LIMITED-LIABILITY-COMPANY
62%
ly owned subsidiary of PK Holdings and a Cayman Islands exempted company, domesticated and continued for purposes of the Delaware Limited Liability Company Act as a Delaware limited liability company…
DOMESTICATION-PROKIDNEY-CORP
DOMESTICATION-PROKIDNEY-CORP
62%
ly owned subsidiary of PK Holdings and a Cayman Islands exempted company, domesticated and continued for purposes of the Delaware Limited Liability Company Act as a Delaware limited liability company…
PK-HOLDINGS
PK-HOLDINGS
62%
ent expenses consist primarily of costs incurred in connection with our research and development activities, including the development of rilparencel. Research and development costs include: • extern…
PK-HOLDINGS-LLC
PK-HOLDINGS-LLC
62%
D and type 2 diabetes and have completed two Phase 2 clinical studies for rilparencel in subjects with advanced CKD and diabetes. Rilparencel has received regenerative medicine advanced therapy (“RMA…
PROKIDNEY-HOLDINGS-LLC
PROKIDNEY-HOLDINGS-LLC
62%
ly owned subsidiary of PK Holdings and a Cayman Islands exempted company, domesticated and continued for purposes of the Delaware Limited Liability Company Act as a Delaware limited liability company…
PROKIDNEY-IPCO-LLC
PROKIDNEY-IPCO-LLC
62%
D and type 2 diabetes and have completed two Phase 2 clinical studies for rilparencel in subjects with advanced CKD and diabetes. Rilparencel has received regenerative medicine advanced therapy (“RMA…
ProKidney Corp. Debt Obligations
Instrument
Description
Confidence
Evidence
PROK-DEBT
Debt stack $4.0M
90%
Market cache reports total debt of $4.0M.
ProKidney Corp. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ProKidney Corp..
ProKidney Corp. Ownership
Holder
Name
Confidence
Evidence
PROK-OWNER-BROWN-UNIVERSITY
Brown University
90%
13F overlay lists Brown University as top holder; 2 tracked holders.
ProKidney Corp. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
